Cargando…
Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review
Most patients with advanced gastric cancer were treated with palliative therapy, which had a poor curative effect and a short survival time. In recent years, the clinical research of immune checkpoint inhibitors in advanced gastric cancer has made a breakthrough and has become an important treatment...
Autores principales: | Shen, Jingjing, Wang, Zhongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730822/ https://www.ncbi.nlm.nih.gov/pubmed/36505771 http://dx.doi.org/10.3389/fonc.2022.934249 |
Ejemplares similares
-
Recent advances progress in radiotherapy for breast cancer after breast-conserving surgery: a review
por: Wang, Yun, et al.
Publicado: (2023) -
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022) -
Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor
por: Chen, Yang, et al.
Publicado: (2021) -
A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
por: El Helali, Aya, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
por: Han, Xiling, et al.
Publicado: (2022)